ClinicalTrials.Veeva

Menu

Central Venous Catheter Insertion Site and Colonization in Pediatric Cardiac Surgery (PRECiSE)

S

San Donato Group (GSD)

Status

Withdrawn

Conditions

Central Venous Catheter Associated Bloodstream Infection
Newborn; Infection
Heart; Surgery, Heart, Functional Disturbance as Result
Congenital Heart Disease
Central Line-associated Bloodstream Infection (CLABSI)

Treatments

Procedure: Internal jugular vein CVC insertion

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Randomized controlled trial comparing femoral vs internal jugular insertion site of central venous catheters (CVC) in newborns and infants undergoing cardiac surgery. The experimental hypothesis is that the jugular insertion site is superior to the femoral in terms of catheter colonization.

Full description

Background: in adult patients, the femoral site of insertion of CVC is notoriously at higher risk of colonization and central-line associated bloodstream infection (CLABSI) than other sites (jugular or subclavian). In pediatric patients, the femoral site is more commonly used than in adult patients, but there is no sound data on catheter colonization and CLABSI related to the insertion site. The experimental hypothesis of this randomized controlled trial (RCT) is that the jugular insertion site is less likely to induce catheter colonization and CLABSI than the femoral site.

Methods: 160 patients under 1 year and scheduled for cardiac surgery will be included in this RCT; patients will be randomly allocated to the jugular (J Group) or Femoral (F Group). CVC insertion will be performed by one out of three selected expert operators.

The primary endpoint is the catheter colonization based on identification of bacterial grow into the catheter at removal time; CLABSI and CRBSI rate based on the same bacterial identification into the catheter tip and in the blood culture performed in case of signs and symptoms of infection.

Secondary endpoints are mechanical complications defined as arterial puncture immediately identified during procedure, hemothorax and pneumothorax; and procedural difficulty during insertion defined as number of attempts, no guidewire progress, duration of the procedure (time from the completion of the sterile precaution barriers and the catheter fixation.

Sex

All

Ages

Under 1 year old

Volunteers

No Healthy Volunteers

Inclusion criteria

Planned cardiac surgery Age <1 year Eligibility for both insertion sites (jugular and femoral) for CVC Availability of at least one out of the three chosen expert operators

Exclusion criteria

Emergency surgery Known vascular anatomic anomalies Previous cardiac surgery in the last 6 months No expert operator availability Intensive Care unit before surgery Central venous catheter inside at the time of randomization

Withdraw criteria (only for the first endpoint):

Impossibility to placement catheter in the selected site.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

0 participants in 2 patient groups

Jugular
Experimental group
Description:
CVC insertion in the left or right internal jugular vein
Treatment:
Procedure: Internal jugular vein CVC insertion
Femoral
Active Comparator group
Description:
CVC insertion in the right or left femoral vein
Treatment:
Procedure: Internal jugular vein CVC insertion

Trial contacts and locations

1

Loading...

Central trial contact

Simona Silvetti, MD; Marco Ranucci, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems